TrialClinical and translational science2025
Impact of Renal Impairment on the Pharmacodynamic and Pharmacokinetic Profiles of Epaminurad, a Novel Uric Acid Transporter 1 Inhibitor.
Seo Yeong Park et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.